Cathay Biotech Stock Hits Day Low Amid Price Pressure at CNY 54.15

Cathay Biotech, Inc., a prominent player in the specialty chemicals sector, experienced a notable decline of 3.99% on March 17, 2026, reaching an intraday low of CNY 54.15. This performance stands in contrast to the China Shanghai Composite, which saw a smaller decline of 0.85% on the same day. Over the past week, Cathay Biotech's stock has decreased by 0.28%, while its performance over the last month shows a modest increase of 2.02%. However, the company has underperformed the broader market over the past year, with a return of 10.89% compared to the China Shanghai Composite's 18.21%. Key financial metrics indicate that Cathay Biotech has faced challenges in management efficiency, reflected in a low Return on Capital Employed (ROCE) of 8.99%. Despite this, the company has reported positive results for the last four consecutive quarters, with a significant reduction in raw material costs year-over-year. The stock currently offers a dividend yield of 0.75%, and its Price to Book ratio stands at 1.76, suggesting a valuation that may attract attention in the specialty chemicals industry.